Option chain shows key data for Apimeds Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Apimeds Pharmaceuticals.

Apimeds Pharmaceuticals (AMEX:APUS) Stock, Option Chain

Apimeds Pharmaceuticals Us Inc is a clinical-stage company. It is engaged in a pharmaceutical business that provides the biological drug Apitox to clients in the biological drug commercial transaction area. It are a clinical stage biopharmaceutical company in the process of developing Apitox, an intradermally administered bee venom-based toxin. Company focus is on developing therapies that address inflammation and pain management symptoms associated with knee OA and, to a lesser extent, MS. Apitox is currently marketed and sold by Apimeds Inc. in South Korea as Apitoxin for the treatment of OA.

Apimeds Pharmaceuticals US, Inc. Common Stock

Apimeds Pharmaceuticals Us Inc

Press Releases

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

APUS

ABVC BioPharma

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Apimeds Pharmaceuticals

BioAtla

BioVie

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Clene

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Curis

CEL-SCI

Elevation Oncology

Generation Bio

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Kala Bio

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Longeveron

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

Nanoviricides

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

OSR Holdings

Ovid Therapeutics

Q32 Bio

Surrozen

Tenax Therapeutics

Tempest Therapeutics, Inc. - Common Stock

Comments

Apimeds Pharmaceuticals

Apimeds Pharmaceuticals (APUS) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell